By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Addex Therapeutics (ADXN.SW) Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., As Chief Medical Officer 11/28/2016 7:30:48 AM
Addex Therapeutics (ADXN.SW) To Conduct Phase IIa Proof Of Concept Study Of Dipraglurant In Focal Cervical Dystonia 10/17/2016 10:28:39 AM
Addex Therapeutics (ADXN.SW) Initiates New Study In Collaboration With U.S. National Institute on Drug Abuse (NIDA) With ADX88178 In Non-Human Primate Model Of Cocaine Addiction 10/11/2016 10:23:25 AM
Addex Therapeutics (ADXN.SW) Reports First Half 2016 Operating Highlights And Financial Results 9/30/2016 8:42:20 AM
Addex Therapeutics (ADXN.SW) Collaborators Published New Data Supporting The Role Of Negative Allosteric Modulators Of Follicle Stimulating Hormone And Luteinizing Hormone Receptors In Reproductive Health 9/20/2016 9:14:43 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Highly Translational Preclinical Model Of Spasticity 7/27/2016 9:33:32 AM
LifeSci Capital Issues Equity Research Report On Addex Therapeutics (ADXN.SW) 7/20/2016 9:35:11 AM
Addex Therapeutics (ADXN.SW) Shareholders Approved All Board Proposals At 2016 Annual General Meeting 6/24/2016 9:04:29 AM
Addex Therapeutics (ADXN.SW) mGluR4 And mGluR7 Programs Demonstrate Potential In Preclinical Models Of Neurodegenerative And Psychiatric Diseases 6/13/2016 9:25:51 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Non-Human Primate Model Of Cocaine Addiction 6/9/2016 12:38:54 PM
12345678910...
//-->